Revenue (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of revenue recognized

The following schedule entails detailed information about the Group’s revenue in the financial year 2025:


		Discovery &
		Preclinical		Just - Evotec
in k€		Development		Biologics		Evotec Group
Revenue from contracts with customers
Fee for services and FTE-based research services		468,515		144,412		612,927
Material re-charges to customers		31,892		—		31,892
Milestone fees		9,615		—		9,615
Licenses		7,314		115,031		122,345
Other fees		300		—		300
Total revenue from contracts with customers		517,636		259,443		777,079
Timing of revenue recognition
At a point in time		49,121		115,031		164,152
Over a period of time		468,515		144,412		612,927
Total revenue from contracts with customers		517,636		259,443		777,079
Revenue from contributions		11,294		—		11,294
Total Revenue		528,930		259,443		788,373

The following schedule entails detailed information about the Group’s revenue in the financial year 2024:


		Discovery &
		Preclinical		Just - Evotec
in k€		Development		Biologics		Evotec Group
Revenue from contracts with customers
Fee for services and FTE-based research services		553,963		183,431		737,394
Material re-charges to customers		38,578		—		38,578
Milestone fees		2,871		—		2,871
Licenses		3,130		—		3,130
Other fees		544		—		544
Total revenue from contracts with customers		599,086		183,431		782,517
Timing of revenue recognition
At a point in time		83,157		44,123		127,280
Over a period of time		515,929		139,308		655,237
Total revenue from contracts with customers		599,086		183,431		782,517
Revenue from contributions		12,308		2,142		14,450
Total Revenue		611,394		185,573		796,967

The following schedule entails detailed information about the Group’s revenue in the financial year 2023:


		Discovery &
		Preclinical		Just - Evotec
in k€		Development		Biologics		Evotec Group
Revenue from contracts with customers
Fee for services and FTE-based research services		619,437		107,492		726,929
Material re-charges to customers		37,561		—		37,561
Milestone fees		4,785		—		4,785
Licenses		674		1		675
Other fees		2,059		—		2,059
Total revenue from contracts with customers		664,516		107,493		772,009
Timing of revenue recognition
At a point in time		42,345		46,242		88,587
Over a period of time		622,171		61,251		683,421
Total revenue from contracts with customers		664,516		107,493		772,009
Revenue from contributions		8,461		956		9,417
Total Revenue		672,977		108,449		781,426

Schedule of transaction price allocated to the remaining performance obligation


in k€		December 31, 2025		December 31, 2024*		December 31, 2023
In the course of the following year		258,618		460,835		571,825
After one year		190,240		885,577		335,427

*Change from prior year disclosed amount

Schedule of contract assets and contract liabilities


in k€		2025		2024
Balance as of January 1		46,034		25,000
Additions		263,025		201,016
Reclassifications to trade receivables due to invoicing		(275,559)		(181,469)
Translation differences and other		(5,205)		1,487
Balance as of December 31		28,295		46,034


		Current				Non-current
in k€		2025		2024		2025		2024
Balance as of January 1		106,599		97,587		156,679		155,287
Additions		141,168		220,121		69,649		94,574
Reduction due to recognition of revenue		(222,724)		(303,748)		—		—
Divestment of affiliated companies		—		(1,069)		—		—
Reclassification from non-current to current		81,004		93,181		(81,004)		(93,182)
Translation differences and other		(1,198)		526		—		—
Balance as of December 31		104,849		106,599		145,324		156,679